These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7696831)
21. Possible variation in bone resorption during the normal menstrual cycle. Schlemmer A; Hassager C; Risteli J; Risteli L; Jensen SB; Christiansen C Acta Endocrinol (Copenh); 1993 Nov; 129(5):388-92. PubMed ID: 8279219 [TBL] [Abstract][Full Text] [Related]
22. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women. Taga M; Shirashu K; Minaguchi H Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177 [TBL] [Abstract][Full Text] [Related]
23. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women. Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515 [TBL] [Abstract][Full Text] [Related]
24. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis. Kawana K; Takahashi M; Hoshino H; Kushida K Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280 [TBL] [Abstract][Full Text] [Related]
25. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523 [TBL] [Abstract][Full Text] [Related]
26. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Rosenquist C; Fledelius C; Christgau S; Pedersen BJ; Bonde M; Qvist P; Christiansen C Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755 [TBL] [Abstract][Full Text] [Related]
27. Age-related changes in bone mineral density and serum bone-related proteins in premenopausal and postmenopausal Japanese women. Yasumizu T; Okuno T; Fukada Y; Hoshi K Endocr J; 2000 Apr; 47(2):103-9. PubMed ID: 10943733 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790 [TBL] [Abstract][Full Text] [Related]
29. Markers of bone resorption--measurement in serum, plasma or urine? Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the clinical performance of the immunoenzymometric assays for N-terminal and C-terminal type I collagen telopeptides and the HPLC assay for pyridinium cross-links. Bettica P; Masino M; Cucinotta E; Vago T; Norbiato G; Moro L; Suarez KN; Romanello M; Bevilacqua M Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):63-8. PubMed ID: 9156570 [TBL] [Abstract][Full Text] [Related]
31. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729 [TBL] [Abstract][Full Text] [Related]
32. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288 [TBL] [Abstract][Full Text] [Related]
33. Usefulness of serum pyridinoline cross-linked carboxy-terminal telopeptides of type I collagen and osteocalcin in the study of the bone resorption rate in oophorectomized rats. Calero JA; De la Piedra C; Díaz Curiel M Miner Electrolyte Metab; 1998; 24(5):303-6. PubMed ID: 9705565 [TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of carboxyterminal cross-linked telopeptide of type I collagen (ICTP), serum tartrate resistant acid phosphatase, and serum levels of intact parathyroid hormone in parathyroid hyperfunction. De la Piedra C; Díaz Martín MA; Díaz Diego EM; López Gavilanes E; González Parra E; Caramelo C; Rapado A Scand J Clin Lab Invest; 1994 Feb; 54(1):11-5. PubMed ID: 8171266 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of bone metastasis from lung cancer. Horiguchi T; Tachikawa S; Kondo R; Hirose M; Teruya S; Ishibashi A; Banno K Jpn J Clin Oncol; 2000 Apr; 30(4):174-9. PubMed ID: 10830985 [TBL] [Abstract][Full Text] [Related]
36. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. Hannon R; Blumsohn A; Naylor K; Eastell R J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios. Carlson K; Larsson A; Simonsson B; Turesson I; Westin J; Ljunghall S Eur J Haematol; 1999 May; 62(5):300-6. PubMed ID: 10359057 [TBL] [Abstract][Full Text] [Related]
38. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study. Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806 [TBL] [Abstract][Full Text] [Related]
39. Serum levels of the pyridinoline crosslinked carboxyterminal telopeptide of type I collagen (ICTP) and osteocalcin in rachitic children in Nigeria. Scariano JK; Walter EA; Glew RH; Hollis BW; Henry A; Ocheke I; Isichei CO Clin Biochem; 1995 Oct; 28(5):541-5. PubMed ID: 8582054 [TBL] [Abstract][Full Text] [Related]
40. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]